Lyra Therapeutics Statistics

Total Valuation

LYRA has a market cap or net worth of $6.24 million. The enterprise value is $7.86 million.

Market Cap	6.24M
Enterprise Value	7.86M

Important Dates

The last earnings date was Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

LYRA has 66.27 million shares outstanding. The number of shares has increased by 15.82% in one year.

Current Share Class	66.27M
Shares Outstanding	66.27M
Shares Change (YoY)	+15.82%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	0.92%
Owned by Institutions (%)	21.99%
Float	47.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.21
Forward PS	8.84
PB Ratio	1.60
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.96, with a Debt / Equity ratio of 8.61.

Current Ratio	2.96
Quick Ratio	2.77
Debt / Equity	8.61
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -195.46% and return on invested capital (ROIC) is -37.00%.

Return on Equity (ROE)	-195.46%
Return on Assets (ROA)	-28.54%
Return on Invested Capital (ROIC)	-37.00%
Return on Capital Employed (ROCE)	-100.71%
Revenue Per Employee	$39,500
Profits Per Employee	-$2.65M
Employee Count	30
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, LYRA has paid $29,000 in taxes.

Income Tax	29,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -74.71% in the last 52 weeks. The beta is 0.05, so LYRA's price volatility has been lower than the market average.

Beta (5Y)	0.05
52-Week Price Change	-74.71%
50-Day Moving Average	0.13
200-Day Moving Average	0.21
Relative Strength Index (RSI)	39.82
Average Volume (20 Days)	3,139,516

Short Selling Information

The latest short interest is 2.70 million, so 4.08% of the outstanding shares have been sold short.

Short Interest	2.70M
Short Previous Month	2.22M
Short % of Shares Out	4.08%
Short % of Float	5.75%
Short Ratio (days to cover)	1.48

Income Statement

In the last 12 months, LYRA had revenue of $1.19 million and -$79.53 million in losses. Loss per share was -$1.21.

Revenue	1.19M
Gross Profit	-29.22M
Operating Income	-45.17M
Pretax Income	-68.82M
Net Income	-79.53M
EBITDA	-44.70M
EBIT	-45.17M
Loss Per Share	-$1.21

Full Income Statement

Balance Sheet

The company has $31.74 million in cash and $33.36 million in debt, giving a net cash position of -$1.62 million or -$0.02 per share.

Cash & Cash Equivalents	31.74M
Total Debt	33.36M
Net Cash	-1.62M
Net Cash Per Share	-$0.02
Equity (Book Value)	3.87M
Book Value Per Share	0.06
Working Capital	22.44M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$56.40 million and capital expenditures -$189,000, giving a free cash flow of -$56.59 million.

Operating Cash Flow	-56.40M
Capital Expenditures	-189,000
Free Cash Flow	-56.59M
FCF Per Share	-$0.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-3,811.39%
Pretax Margin	-6,708.95%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LYRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.82%
Shareholder Yield	-15.82%
Earnings Yield	-1,274.03%
FCF Yield	-906.50%

Analyst Forecast

The average price target for LYRA is $1.25, which is 1,226.96% higher than the current price. The consensus rating is "Hold".

Price Target	$1.25
Price Target Difference	1,226.96%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	135.52%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LYRA has an Altman Z-Score of -11.9 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-11.9
Piotroski F-Score	2